Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
127M
-
Number of holders
-
63
-
Total 13F shares, excl. options
-
57.9M
-
Shares change
-
-1.86M
-
Total reported value, excl. options
-
$48.9M
-
Value change
-
-$1.4M
-
Number of buys
-
16
-
Number of sells
-
-38
-
Price
-
$0.84
Significant Holders of Nautilus Biotechnology, Inc. - Common Stock, $0.0001 par value per share (NAUT) as of Q3 2025
75 filings reported holding NAUT - Nautilus Biotechnology, Inc. - Common Stock, $0.0001 par value per share as of Q3 2025.
Nautilus Biotechnology, Inc. - Common Stock, $0.0001 par value per share (NAUT) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57.9M shares
of 127M outstanding shares and own 45.62% of the company stock.
Largest 10 shareholders include a16z Capital Management, L.L.C. (17.7M shares), PERCEPTIVE ADVISORS LLC (12.6M shares), Cercano Management LLC (7.17M shares), Madrona Venture Group, LLC (6.02M shares), VANGUARD GROUP INC (2.43M shares), Comprehensive Financial Management LLC (2.21M shares), AMAZON COM INC (1.46M shares), Clarius Group, LLC (1.21M shares), RENAISSANCE TECHNOLOGIES LLC (1.01M shares), and MILLENNIUM MANAGEMENT LLC (968K shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.